232 related articles for article (PubMed ID: 33425733)
1. Cancer during pregnancy: A qualitative study of healthcare experiences of Australian women.
Stafford L; Sinclair M; Gerber K; Collins L; Newman L; Saunders C; Ives A; Mason KD; Peate M; Lippey J; Umstad MP; Shanahan K; Little R
Eur J Cancer Care (Engl); 2021 Jul; 30(4):e13425. PubMed ID: 33569843
[TBL] [Abstract][Full Text] [Related]
2. Cancer during Pregnancy: A Review of Preclinical and Clinical Transplacental Transfer of Anticancer Agents.
Benoit L; Mir O; Vialard F; Berveiller P
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33799824
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy-associated breast cancer: nationwide Dutch study confirms a discriminatory aggressive histopathologic profile.
Suelmann BBM; van Dooijeweert C; van der Wall E; Linn S; van Diest PJ
Breast Cancer Res Treat; 2021 Apr; 186(3):699-704. PubMed ID: 33635448
[TBL] [Abstract][Full Text] [Related]
4. Oncoproteins of High-Risk HPV and EBV Cooperate to Enhance Cell Motility and Invasion of Human Breast Cancer Cells
Gupta I; Jabeen A; Vranic S; Al Moustafa AE; Al-Thawadi H
Front Oncol; 2021; 11():630408. PubMed ID: 33777781
[TBL] [Abstract][Full Text] [Related]
5. Postpartum breast cancer: mechanisms underlying its worse prognosis, treatment implications, and fertility preservation.
Lefrère H; Lenaerts L; Borges VF; Schedin P; Neven P; Amant F
Int J Gynecol Cancer; 2021 Mar; 31(3):412-422. PubMed ID: 33649008
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy associated breast cancer (PABC): Report from a gestational cancer registry from a tertiary cancer care centre, India.
Bajpai J; Simha V; Shylasree TS; Sarin R; Pathak R; Popat P; Mokal S; Dandekar S; Bhansal V; Ghosh J; Nair N; Gulia S; Rath S; Joshi S; Wadasadawala T; Sheth T; Parmar V; Banavali SD; Badwe RA; Gupta S
Breast; 2021 Apr; 56():88-95. PubMed ID: 33640524
[TBL] [Abstract][Full Text] [Related]
7. Premenopausal women with breast cancer in the early post-partum period show molecular profiles of invasion and are associated with poor prognosis.
Nimbalkar VP; Snijesh VP; Rajarajan S; Alexander A; Kaluve R; Ramesh R; Srinath BS; Prabhu JS
Breast Cancer Res Treat; 2023 Jul; 200(1):139-149. PubMed ID: 37160509
[TBL] [Abstract][Full Text] [Related]
8. Postpartum breast cancer has a distinct molecular profile that predicts poor outcomes.
Jindal S; Pennock ND; Sun D; Horton W; Ozaki MK; Narasimhan J; Bartlett AQ; Weinmann S; Goss PE; Borges VF; Xia Z; Schedin P
Nat Commun; 2021 Nov; 12(1):6341. PubMed ID: 34732713
[TBL] [Abstract][Full Text] [Related]
9. The definition of pregnancy-associated breast cancer is outdated and should no longer be used.
Amant F; Lefrère H; Borges VF; Cardonick E; Lambertini M; Loibl S; Peccatori F; Partridge A; Schedin P
Lancet Oncol; 2021 Jun; 22(6):753-754. PubMed ID: 34087122
[No Abstract] [Full Text] [Related]
10. Chitin-mediated blockade of chitinase-like proteins reduces tumor immunosuppression, inhibits lymphatic metastasis and enhances anti-PD-1 efficacy in complementary TNBC models.
Salembier R; De Haes C; Bellemans J; Demeyere K; Van Den Broeck W; Sanders NN; Van Laere S; Lyons TR; Meyer E; Steenbrugge J
Breast Cancer Res; 2024 Apr; 26(1):63. PubMed ID: 38605414
[TBL] [Abstract][Full Text] [Related]
11. Metastatic Breast Cancer Presenting As Neck Pain in a Pregnant Patient.
Chu EC; Yun SMH
Cureus; 2024 Jan; 16(1):e51444. PubMed ID: 38298289
[TBL] [Abstract][Full Text] [Related]
12. Gestational Breast Cancer - a Review of Outcomes, Pathophysiology, and Model Systems.
Callaway MK; Dos Santos CO
J Mammary Gland Biol Neoplasia; 2023 Jul; 28(1):16. PubMed ID: 37450228
[TBL] [Abstract][Full Text] [Related]
13. Breast Carcinogenesis during Pregnancy: Molecular Mechanisms, Maternal and Fetal Adverse Outcomes.
Margioula-Siarkou G; Margioula-Siarkou C; Petousis S; Vavoulidis E; Margaritis K; Almperis A; Haitoglou C; Mavromatidis G; Dinas K
Biology (Basel); 2023 Mar; 12(3):. PubMed ID: 36979100
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy-Associated Breast Cancer: A Diagnostic and Therapeutic Challenge.
Galati F; Magri V; Arias-Cadena PA; Moffa G; Rizzo V; Pasculli M; Botticelli A; Pediconi F
Diagnostics (Basel); 2023 Feb; 13(4):. PubMed ID: 36832092
[TBL] [Abstract][Full Text] [Related]
15. Modulatory role of miRNAs in thyroid and breast cancer progression and insights into their therapeutic manipulation.
Ahmed R; Samanta S; Banerjee J; Kar SS; Dash SK
Curr Res Pharmacol Drug Discov; 2022; 3():100131. PubMed ID: 36568259
[TBL] [Abstract][Full Text] [Related]
16. Updated Neoadjuvant Treatment Landscape for Early Triple Negative Breast Cancer: Immunotherapy, Potential Predictive Biomarkers, and Novel Agents.
Garufi G; Carbognin L; Schettini F; Seguí E; Di Leone A; Franco A; Paris I; Scambia G; Tortora G; Fabi A
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077601
[TBL] [Abstract][Full Text] [Related]
17. Breast Cancer During Pregnancy: A Marked Propensity to Triple-Negative Phenotype.
Allouch S; Gupta I; Malik S; Al Farsi HF; Vranic S; Al Moustafa AE
Front Oncol; 2020; 10():580345. PubMed ID: 33425733
[TBL] [Abstract][Full Text] [Related]
18. Clinical Characteristics and Prognosis of Pregnancy-Associated Breast Cancer: Poor Survival of Luminal B Subtype.
Bae SY; Jung SP; Jung ES; Park SM; Lee SK; Yu JH; Lee JE; Kim SW; Nam SJ
Oncology; 2018; 95(3):163-169. PubMed ID: 29913459
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
